Clinigen Group PLC with EPIC/TICKER (LON:CLIN) had its stock rating noted as ‘Unchanged’ with the recommendation being set at ‘TOP PICK’ this morning by analysts at RBC Capital Markets. Clinigen Group PLC are listed in the Health Care sector within AIM. RBC Capital Markets have set a target price of 1640 GBX on its stock. This indicates the analyst now believes there is a potential upside of 75.7% from the opening price of 933.5 GBX. Over the last 30 and 90 trading days the company share price has increased 163 points and increased 37.5 points respectively. The 52 week high for the share price is currently at 1065 GBX while the 52 week low is 716 GBX.
Clinigen Group PLC has a 50 day moving average of 805.41 GBX and the 200 Day Moving Average price is recorded at 894.63. There are currently 132,433,092 shares in issue with the average daily volume traded being 495,948. Market capitalisation for LON:CLIN is £1,222,357,439 GBP.
